marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Evofem Biosciences Balance Sheet 2011-2024 | EVFM
Annual Balance Sheet Evofem Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-475 K | 2.68 M | -976 K | 28.7 M | -15.4 M | 2.68 M | -3.42 M | -11.5 M | -27.8 M | -66.2 M | -4.16 M | -10.5 M | - |
Long Term Debt |
8 K | 3.13 M | 4.42 M | 25.2 M | - | - | - | - | 7.21 M | 9.74 M | - | - | - |
Long Term Debt Current |
97 K | 2.31 M | 2.33 M | 2.29 M | 197 K | - | - | - | 2.76 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 31.3 M | - | 37 K | - | - | 7.21 M | 9.74 M | 2.2 M | 1.62 M | - |
Total Current Liabilities |
72.5 M | 93.8 M | 138 M | 77.3 M | 12.7 M | 27.3 M | 103 M | 902 K | 9.1 M | - | - | - | - |
Total Liabilities |
72.5 M | 97 M | 142 M | 109 M | 12.7 M | 27.4 M | 1.41 M | 902 K | 16.3 M | 11.7 M | 3.73 M | 3.53 M | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-889 M | -939 M | -861 M | -655 M | -513 M | -433 M | -136 M | -126 M | -113 M | -69.7 M | -58.9 M | -43.8 M | - |
Total Assets |
10.6 M | 25.2 M | 42.5 M | 110 M | 28.3 M | 4.01 M | 4.12 M | 12.8 M | 40.1 M | 76.9 M | 4.53 M | 12.8 M | - |
Cash and Cash Equivalents |
580 K | 2.77 M | 7.73 M | 48.9 M | 15.6 M | 1.33 M | 3.42 M | 11.5 M | 37.7 M | 75.9 M | 4.36 M | - | - |
Book Value |
-61.9 M | -71.8 M | -99.6 M | 1.35 M | 15.6 M | -23.4 M | 2.71 M | 11.9 M | 23.8 M | 65.2 M | 797 K | 9.3 M | - |
Total Shareholders Equity |
-66.5 M | -71.8 M | -104 M | 1.35 M | 15.6 M | -23.4 M | -290 M | -181 M | 23.8 M | 65.2 M | -56.7 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Evofem Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
10 K | 1 K | 4 K | 8 K | 13 K | 22 K | 2.63 M | 3.13 M | 3.62 M | 3.91 M | 4.06 M | 4.42 M | 26.7 M | 26.2 M | 25.7 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.81 M | 3.15 M | 7.21 M | 7.21 M | 7.21 M | 7.21 M | 9.74 M | 9.74 M | 9.74 M | 9.74 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
90.1 M | 73.2 M | 74.2 M | 72.5 M | 67.9 M | 69.7 M | 82.4 M | 97 M | 120 M | 269 M | 159 M | 142 M | 126 M | 99.8 M | 107 M | 109 M | 109 M | 109 M | 109 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 27.4 M | 27.4 M | 27.4 M | 27.4 M | 104 M | 104 M | 104 M | 104 M | 17.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
4.5 M | 3.6 M | 3.2 M | 3.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-895 M | -892 M | -894 M | -889 M | -885 M | -950 M | -941 M | -939 M | -930 M | -1.02 B | -893 M | -861 M | -809 M | -735 M | -702 M | -655 M | -655 M | -655 M | -655 M | -513 M | -513 M | -513 M | -513 M | -433 M | -433 M | -433 M | -433 M | -307 M | -307 M | -307 M | -307 M | -202 M | -126 M | -126 M | -126 M | -113 M | -113 M | -113 M | -113 M | -69.7 M | -69.7 M | -69.7 M | -69.7 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
23.9 M | 8.55 M | 8.22 M | 10.6 M | 13.3 M | 14.1 M | 26 M | 25.2 M | 42.3 M | 53.5 M | 34.6 M | 42.5 M | 67.4 M | 109 M | 93.5 M | 110 M | 110 M | 110 M | 110 M | 28.3 M | 28.3 M | 28.3 M | 28.3 M | 4.01 M | 4.01 M | 4.01 M | 4.01 M | 3.95 M | 3.95 M | 3.95 M | 3.95 M | 14.4 M | 12.8 M | 12.8 M | 12.8 M | 40.1 M | 40.1 M | 40.1 M | 40.1 M | 76.9 M | 76.9 M | 76.9 M | 76.9 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
722 K | 692 K | 689 K | 580 K | 410 K | 636 K | 639 K | 2.77 M | 7.75 M | 19.9 M | 2.76 M | 7.73 M | 14.9 M | 47 M | 45.3 M | 48.9 M | 48.9 M | 48.9 M | 48.9 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 1.33 M | 1.33 M | 1.33 M | 1.33 M | 1.21 M | 1.21 M | 1.21 M | 1.21 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 37.7 M | 37.7 M | 37.7 M | 37.7 M | 75.9 M | 75.9 M | 75.9 M | 75.9 M | 4.36 M | - | - | - | 11.1 M | - | - | - | - | - | - | - |
Book Value |
-66.1 M | -64.6 M | -66 M | -61.9 M | -54.6 M | -55.7 M | -56.4 M | -71.8 M | -78 M | -216 M | -124 M | -99.6 M | -58.8 M | 8.96 M | -13.6 M | 1.35 M | 1.35 M | 1.35 M | 1.35 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | -23.4 M | -23.4 M | -23.4 M | -23.4 M | -99.7 M | -99.7 M | -99.7 M | -99.7 M | -3.01 M | 12.8 M | 12.8 M | 12.8 M | 40.1 M | 40.1 M | 40.1 M | 40.1 M | 76.9 M | 76.9 M | 76.9 M | 76.9 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-70.9 M | -69.3 M | -70.7 M | -66.5 M | -56.4 M | -55.7 M | -56.4 M | -71.8 M | -78 M | -216 M | -128 M | -104 M | -58.8 M | 8.96 M | -13.6 M | 1.35 M | 1.35 M | 1.35 M | 1.35 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | -23.4 M | -23.4 M | -23.4 M | -23.4 M | -290 M | -290 M | -290 M | -290 M | -181 M | 11.9 M | 11.9 M | 11.9 M | -120 M | 23.8 M | 23.8 M | 23.8 M | 65.2 M | 65.2 M | 65.2 M | 65.2 M | -56.7 M | - | - | - | -41.8 M | - | - | - | - | - | - | - |
All numbers in USD currency